To deepen the knowledge on PFKFB3 in breast cancer and to aid the potential use of future inhibitors, secondary aims were to study PFKFB3 levels in different breast cancer subtypes, to correlate it to clinicopathologically relevant factors, gene expression pathways and outcome. The gene discussed is PFKFB3; the disease is breast carcinoma.